On October 22, 2012, Governor Deval Patrick today joined Genzyme, a Sanofi subsidiary and the world’s third-largest biotechnology company, at an open house to celebrate the recent opening of the company’s new biomanufacturing facility in Framingham. The Massachusetts Life Sciences Center (MLSC) awarded grant funding totaling $14.3 million to the town of Framingham to upgrade its wastewater collection system in conjunction with Genzyme’s large-scale biomanufacturing expansion project.
